These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 27593939)
1. UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy. Hu L; Li X; Liu Q; Xu J; Ge H; Wang Z; Wang H; Wang Z; Shi C; Xu X; Huang J; Lin Z; Pieper RO; Weng C Oncogene; 2017 Feb; 36(8):1145-1156. PubMed ID: 27593939 [TBL] [Abstract][Full Text] [Related]
2. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells. Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449 [TBL] [Abstract][Full Text] [Related]
3. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme. Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205 [TBL] [Abstract][Full Text] [Related]
4. UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1. Han Z; Xu L; Wang A; Wang B; Liu Q; Liu H; Liu Q; Gang Z; Yu S; Mu L; Weng C; Lin Z; Hu L Int J Biol Macromol; 2024 Oct; 278(Pt 1):134426. PubMed ID: 39098687 [TBL] [Abstract][Full Text] [Related]
5. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair. Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Downregulates Ubiquitin-Conjugating Enzyme E2S Expression To Prevent Proteasomal Degradation of NS5A, Leading to Host Cells More Sensitive to DNA Damage. Pham HT; Nguyen TTT; Nguyen LP; Han SS; Lim YS; Hwang SB J Virol; 2019 Jan; 93(2):. PubMed ID: 30381483 [TBL] [Abstract][Full Text] [Related]
7. Discovery of UMI-77 as a novel Ku70/80 inhibitor sensitizing cancer cells to DNA damaging agents in vitro and in vivo. Chen X; Chen C; Luo C; Liu J; Lin Z Eur J Pharmacol; 2024 Jul; 975():176647. PubMed ID: 38754534 [TBL] [Abstract][Full Text] [Related]
8. Cloning, localization and focus formation at DNA damage sites of canine Ku70. Koike M; Yutoku Y; Koike A J Vet Med Sci; 2017 Mar; 79(3):554-561. PubMed ID: 28163277 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Investigation into the Role of Ubiquitin-Conjugating Enzyme E2S in Melanoma Development. Wang P; Li Y; Ma Y; Zhang X; Li Z; Yu W; Zhu M; Wang J; Xu Y; Xu A J Invest Dermatol; 2021 Feb; 141(2):374-384. PubMed ID: 32603752 [TBL] [Abstract][Full Text] [Related]
10. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation. Guan J; Zhao Q; Mao W Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411 [TBL] [Abstract][Full Text] [Related]
11. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair. Li L; Ye S; Yang M; Yu W; Fan Z; Zhang H; Hu J; Liang A; Zhang W Oncol Rep; 2015 Dec; 34(6):2935-42. PubMed ID: 26398583 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair. Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744 [TBL] [Abstract][Full Text] [Related]
13. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system. Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844 [TBL] [Abstract][Full Text] [Related]
14. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining. Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350 [TBL] [Abstract][Full Text] [Related]
15. Nuclear GSK3β induces DNA double-strand break repair by phosphorylating 53BP1 in glioblastoma. Yang Y; Lei T; Du S; Tong R; Wang H; Yang J; Huang J; Sun M; Wang Y; Dong Z Int J Oncol; 2018 Mar; 52(3):709-720. PubMed ID: 29328365 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of Ku dictates DNA double-strand break (DSB) repair pathway choice in S phase. Lee KJ; Saha J; Sun J; Fattah KR; Wang SC; Jakob B; Chi L; Wang SY; Taucher-Scholz G; Davis AJ; Chen DJ Nucleic Acids Res; 2016 Feb; 44(4):1732-45. PubMed ID: 26712563 [TBL] [Abstract][Full Text] [Related]
17. A novel small molecule inhibitor of the DNA repair protein Ku70/80. Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816 [TBL] [Abstract][Full Text] [Related]
18. A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer. Wu YH; Hong CW; Wang YC; Huang WJ; Yeh YL; Wang BJ; Wang YJ; Chiu HW Cancer Lett; 2017 Aug; 400():79-88. PubMed ID: 28450160 [TBL] [Abstract][Full Text] [Related]
19. PAXX Is an Accessory c-NHEJ Factor that Associates with Ku70 and Has Overlapping Functions with XLF. Tadi SK; Tellier-Lebègue C; Nemoz C; Drevet P; Audebert S; Roy S; Meek K; Charbonnier JB; Modesti M Cell Rep; 2016 Oct; 17(2):541-555. PubMed ID: 27705800 [TBL] [Abstract][Full Text] [Related]
20. Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair. Toulany M; Lee KJ; Fattah KR; Lin YF; Fehrenbacher B; Schaller M; Chen BP; Chen DJ; Rodemann HP Mol Cancer Res; 2012 Jul; 10(7):945-57. PubMed ID: 22596249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]